Every product manager or formulation chemist working with sensitive actives eventually hits a critical fork in the road: Should we spec a Delayed Release (DR) acid-resistant capsule, or do we actually need a True Enteric capsule?
Making the wrong choice here gets expensive fast. Pick a standard DR shell for an ultra-sensitive enzyme, and you risk post-market stability failures when stomach acid destroys your active ingredients. On the flip side, specifying a heavy-duty enteric capsule for a mild botanical extract adds unnecessary raw material costs and slows down your supply chain.
There is a lot of loose marketing terminology floating around the hollow capsule market today. Let's strip away the sales pitch and break down the exact performance differences, cost tradeoffs, and manufacturing realities so you can spec the right shell for your exact formulation.
1. The Core Mechanical Difference: Swelling Hydrogel vs. Acid Insoluble Barrier
To pick the right shell, you first need to understand how these two capsules behave differently under gastric acid.
- DR (Delayed Release / Acid-Resistant) Capsules: These are usually made by blending HPMC with natural gel-forming polymers like gellan gum or pectin directly into the shell wall. When the capsule hits the stomach, these polymers absorb fluid and swell into a thick hydrogel. This hydrogel slows down fluid penetration for about 60 to 120 minutes. It does not completely lock out fluid; it delays it.
- True Enteric Capsules: These use pH-responsive polymers that are physically insoluble in acid (pH 1.0 to 3.0). The shell wall acts as an impermeable barrier in the stomach. Once the capsule passes the pylorus into the duodenum (where pH rises above 5.5 to 6.8), the polymer matrix dissolves rapidly for targeted intestinal release.
2. Side-by-Side Evaluation: The B2B Selection Matrix
When evaluating empty capsule specifications for commercial production, procurement and QA teams need to weigh six distinct factors. Here is how DR and True Enteric capsules stack up across raw performance, cost, and machine speed:
| Selection Criteria | DR (Acid-Resistant) Capsules | True Enteric Capsules |
|---|---|---|
| Primary Function | Delays dissolution in gastric acid | Locks out 100% of gastric fluid (Zero Leakage) |
| Gastric Release Rate (pH 1.2, 2 hrs) | 5% – 12% Slow Leakage | 0.00% (Strictly Impermeable) |
| Target Intestinal Release (pH 6.8) | Gradual dissolution over 30–60 mins | Rapid dissolution (>88% within 30 mins) |
| Typical Best-Fit Formulations | Standard probiotics, herbals, mild enzymes | Nattokinase, Serrapeptase, SAM-e, sensitive strains |
| Relative Raw Material Cost | Standard / Cost-Effective ($) | Premium Specialized ($$) |
| High-Speed Machine Machinability | Excellent (<0.01% defect) | Excellent (<0.01% defect with pre-coated shells) |
3. Formulation Rules of Thumb: When to Spec Which Shell
If you are stuck choosing between the two options during R&D bench testing, follow these battle-tested rules of thumb from our application engineering team:
Choose DR (Acid-Resistant) Capsules If:
- Your Active Can Tolerate Mild Acid Exposure: Standard multi-strain probiotics (with adequate overages), herbal extracts, or mild digestive enzymes (like papain or bromelain) that don't immediately denature in low acid.
- You Want a Clean-Label Marketing Hook: DR capsules are widely recognized as non-GMO, vegan, and organic-compliant, making them a strong selling point for consumer-facing natural health brands.
- Your Priority is Speed & Margin: DR capsules run seamlessly on high-speed filling lines at standard cost points without needing complex stability testing.
Choose True Enteric Capsules If:
- Your Active is Completely Destroyed by Gastric Acid: Systemic enzymes (like Nattokinase, Serrapeptase, or Trypsin), SAM-e, Glutathione, or live bacterial strains highly vulnerable to stomach acid.
- The Raw Material Causes Severe Gastric Irritation: Highly concentrated iron salts, garlic extracts, or acidic botanicals that cause heartburn or reflux if released in the stomach.
- You Need Guaranteed USP/ChP Enteric Compliance: Your product is bound by strict pharmaceutical or international regulatory release profiles requiring 0.00% gastric release in simulated stomach fluid.
4. Real-World Tradeoffs: Machinability & Supply Chain Reality
From a contract manufacturing (CMO) standpoint, a capsule isn't just a delivery vehicle; it’s raw material running through a high-speed machine.
In the past, enteric capsules meant secondary coating—filling standard gelatin or HPMC shells first, then spraying them with an acrylic or phthalate coating in a pan coater. That added 3 to 5 extra days to production, introduced heat and moisture stress to sensitive powders, and often resulted in brittle shells that chipped during bottling.
Modern Enteric Technology: EEK’s pre-integrated Enteric HPMC Capsules eliminate secondary coating entirely. The enteric functionality is engineered directly into the capsule wall. This means:
- Zero Line Re-Tooling: You fill them on standard encapsulation equipment (Bosch, IMA, Futura) using standard sizing pins and dosing disks.
- Low Defect Rates: Mechanical cracking rates remain under 0.01%, keeping your batch yield high and your factory floor clean.
Make the Data-Backed Choice for Your Pipeline
There is no "one-size-fits-all" capsule shell. DR capsules offer an outstanding, cost-effective balance of delayed release and clean-label appeal for 80% of dietary supplements. But when your formulation contains high-value, highly acid-sensitive actives, True Enteric capsules are the only way to guarantee 100% potency at the target absorption site.
Not sure which capsule fits your powder profile? Don't waste expensive raw materials on trial and error. Contact our technical team today to request a dual sample kit (DR & True Enteric) for machine trials or submit your formulation specs for a confidential engineering review.
• Direct WhatsApp / Mobile: +86 13561623550
• Technical Sales Email: kevin@eekpharma.com
• Official Website: www.eekpharma.com